Colorectal Cancer: Polyps, Staging and Treatment | Part 1 | 大腸 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Colorectal carcinogenesis often unfolds over years,
creating opportunities for prevention before invasive disease develops.
Normal mucosa becomes an adenoma when APC is inactivated,
advances when KRAS mutates,
and turns malignant only after TP53 and SMAD4 fail.
Accumulating these events takes five to ten years, sometimes fifteen,
which is why removing adenomas at colonoscopy prevents cancer.
Two faster lanes exist.
The serrated pathway runs through BRAF and microsatellite instability.
In Lynch syndrome,
defective mismatch repair drives a few adenomas rapidly to cancer,
usually right-sided and often paired with endometrial cancer.
Peutz-Jeghers syndrome, from STK11, brings hamartomas and mucocutaneous pigmentation,
while familial adenomatous polyposis, from APC, carpets the colon with adenomas.
Obesity and inactivity increase risk rather than reduce it.

Stage directs treatment.
Node-positive stage III colon cancer receives adjuvant FOLFOX or CAPOX,
oxaliplatin with a fluoropyrimidine, and no targeted agent.
Targeted therapy belongs to metastatic stage IV disease: bevacizumab broadly,
and cetuximab
or panitumumab only for RAS wild-type tumours of the left colon
and rectum.
The rectum sits in the pelvis and recurs locally more often,
so locally advanced rectal cancer receives neoadjuvant chemoradiotherapy, then total mesorectal excision,
then adjuvant chemotherapy.
TME follows the embryological plane of the mesorectal fascia,
removing the mesorectum intact while sparing the hypogastric and pelvic splanchnic nerves.
Sexual and bladder function are consequently not worsened.

Laparoscopic resection matches open surgery oncologically,
as the COLOR and COST trials showed,
with faster recovery and unchanged mortality.

Colorectal carcinogenesis often unfolds over years,
creating opportunities for prevention before invasive disease develops.


The dentate line divides the anal canal into two worlds,
because endoderm meets ectoderm there.
Above it the epithelium is columnar
and the superior rectal artery arrives from the inferior mesenteric.
Venous blood returns to the portal system, innervation is autonomic and painless,
lymph drains to internal iliac nodes, and haemorrhoids are internal.
Below it the epithelium is squamous
and the inferior rectal artery arises from the internal pudendal.
Blood returns to the inferior vena cava,
the pudendal nerve from S2 to S4 makes every lesion painful,
lymph drains to superficial inguinal nodes, and haemorrhoids are external.
Portal hypertension distends the anastomosis between the two systems.
The middle rectal artery comes from the internal iliac,
not the inferior mesenteric, whose branches are the left colic,
sigmoid and superior rectal arteries.

The sigmoid perforates more than any other segment,
not because its wall is thin but because diverticula are common
and its calibre is small.
By Laplace's law wall tension equals pressure multiplied by radius,
so a narrow lumen needs higher pressure to generate the same tension,
and thin-walled diverticula give way first.
Hinchey grades the consequences: a pericolic abscess is treated with antibiotics,
a pelvic abscess with antibiotics and CT-guided drainage,
and purulent or faecal peritonitis with emergency surgery.
A colovesical fistula is repaired electively,
and chronic anaemia is never an emergency indication.

Colorectal carcinogenesis often unfolds over years,
creating opportunities for prevention before invasive disease develops.

Medical Notes · 醫學學習提示

  1. 大腸癌常經多年形成;圖為正常大腸示意
  2. 篩檢與切除癌前病灶可降低風險
  3. APC 失活是傳統腺瘤途徑常見早期事件
  4. KRAS 可促進進展,但不是每個病灶都突變
  5. 更正:癌化不必一律等 TP53 與 SMAD4 都失效
  6. 進展速度不一,5–10年不是每個病灶的固定時鐘
  7. 切除腺瘤可預防部分癌症,之後仍需風險分層追蹤
  8. 另有鋸齒狀與錯配修復缺陷等途徑
  9. 鋸齒狀途徑常見 BRAF;並非全部都有 MSI
  10. Lynch 症候群是遺傳性癌症風險症候群
  11. 錯配修復缺陷可加快進展,不能只靠息肉數量排除
  12. 常見近端大腸癌,也增加子宮內膜癌等風險
  13. STK11 相關 Peutz–Jeghers:錯構瘤與黏膜皮膚色素斑
  14. APC 相關家族性腺瘤性息肉症可有大量腺瘤
  15. 肥胖及缺乏活動會增加大腸癌風險
  16. 治療須結合分期、分子檢測與整體病況
  17. 第三期結腸癌切除後,常用 FOLFOX 或 CAPOX
  18. 含 oxaliplatin 與氟嘧啶;標靶非例行輔助治療
  19. 轉移性治療依分子與風險選藥,不是人人用 bevacizumab
  20. 抗 EGFR 選擇須看 RAS、BRAF、部位與治療線別
  21. 左側 RAS 野生型常適用;特定 KRAS 標靶合併療法另論
  22. 不是只凭左右側決策,亦須評估 MSI/MMR
  23. 直腸位於骨盆,須評估局部復發與遠端轉移風險
  24. 現行可採全程新輔助治療;MSI-H/dMMR 可評估免疫治療
  25. 術後是否再化療,依術前療程與病理風險決定
  26. TME 沿適當筋膜平面切除直腸繫膜
  27. 完整切除兼顧骨盆自主神經保護
  28. 更正:保留神經可降低風險,但不能保證性與排尿功能不變
  29. 適當病人由有經驗團隊執行,腹腔鏡可有相近腫瘤結果
  30. COLOR、COST 支持結腸癌腹腔鏡的腫瘤學安全性
  31. 復原常較快;風險仍依病況與手術而異
  32. 大腸癌形成常需多年,但不同途徑速度不同
  33. 癌前病灶處理與持續追蹤同樣重要
  34. 齒狀線是肛管重要分界;此圖為大腸概觀
  35. 反映胚胎來源與上皮、神經及引流的轉換
  36. 上方主要為柱狀上皮,交界區有過渡上皮
  37. 上直腸動脈來自下腸繫膜動脈
  38. 上直腸靜脈通往門脈;上方對切割痛較不敏感,非絕無痛
  39. 上方可向內髂及下腸繫膜淋巴引流;內痔在齒狀線上
  40. 下方主要為複層鱗狀上皮
  41. 下直腸動脈通常源自內陰部動脈
  42. 下方靜脈循體循環回流,與上方有交通
  43. 陰部神經 S2–S4 傳遞痛覺;不是每個病灶必疼痛
  44. 齒狀線下主要引流至淺腹股溝淋巴結;外痔在下方
  45. 門脈高壓可造成直腸靜脈曲張,與一般痔瘡不同
  46. 中直腸動脈通常源自內髂,走行有變異
  47. 下腸繫膜動脈分支包括左結腸動脈
  48. 另包括乙狀結腸與上直腸動脈
  49. 乙狀結腸憩室炎可穿孔;不是所有病因都以此處最多
  50. 憩室常是黏膜與黏膜下層穿過肌層薄弱處
  51. 腸徑、分節壓力與發炎等共同影響風險
  52. 簡化圓筒模型:壁張力與壓力乘半徑相關
  53. 同張力下小半徑需較高壓,不能據此單獨推定腸內壓
  54. 憩室結構薄弱加上發炎可導致穿孔
  55. 憩室膿瘍需抗生素;是否引流不能只看位置
  56. 較大或治療反應不佳的膿瘍,評估影像導引引流
  57. 廣泛化膿或糞便性腹膜炎需緊急外科評估處置
  58. 結腸膀胱瘻通常擇期處理;敗血症等可改變急迫性
  59. 更正:慢性貧血本身不等於急診開刀;不穩定或重症仍須急治
  60. 大腸癌常經多年進展,持續追蹤不能省略
  61. 及早辨識、病理檢查與分層處置可改善預後

References